-
Putative salivary protein biomarkers for the diagnosis of oral lichen planus: A case-control study
- Back
Metadata
Document Title
Putative salivary protein biomarkers for the diagnosis of oral lichen planus: A case-control study
Author
Talungchit S., Buajeeb W., Lerdtripop C., Surarit R., Chairatvit K., Roytrakul S., Kobayashi H., Izumi Y., Khovidhunkit S.-O.P.
Name from Authors Collection
Affiliations
Mahidol University, Department of Oral Biology, Faculty of Dentistry, Bangkok, Thailand; Srinakharinwirot University, Department of Oral Surgery and Oral Medicine, Faculty of Dentistry, Bangkok, Thailand; Mahidol University, Department of Oral Medicine and Periodontology, Faculty of Dentistry, Bangkok, Thailand; Mahidol University, Department of Advanced General Dentistry, Faculty of Dentistry, 6 Yodhi St., Rajthewee, Bangkok, 10400, Thailand; National Science and Technology Development Agency, National Center for Genetic Engineering and Biotechnology, Pathumthani, Thailand; Tokyo Medical and Dental University, Department of Periodontology, Graduate School of Medical and Dental Sciences, Tokyo, Japan; Tokyo Medical and Dental University, Global Center of Excellence Program for Tooth and Bone Research, Tokyo, Japan
Type
Article
Source Title
BMC Oral Health
ISSN
14726831
Year
2018
Volume
18
Issue
1
Open Access
Gold, Green
Publisher
BioMed Central Ltd.
DOI
10.1186/s12903-018-0504-8
Abstract
Background: Salivary protein biomarkers for screening and diagnosis of oral lichen planus (OLP) are not well-defined. The objective of this study was to identify putative protein biomarkers for OLP using proteomic approaches. Methods: Pooled unstimulated whole saliva was collected from five OLP patients and five healthy control participants. Saliva samples were then subjected to two-dimensional gel electrophoresis, followed by mass spectrometry to identify putative protein biomarkers. Subsequently, a subset of these putative biomarkers were validated in 24 OLP patients and 24 age-matched healthy control subjects, using an enzyme-linked immunosorbent assay (ELISA). Immunoblotting analyses were then performed in 3 pairs of age- and sex-matched OLP patients and healthy controls to confirm results from the ELISA study. Results: Thirty-one protein spots were identified, corresponding to 20 unique proteins. Notably, fibrinogen fragment D and complement component C3c exhibited increased expression in OLP patients, while cystatin SA exhibited decreased expression in OLP patients, compared with healthy control subjects. ELISA analyses indicated increased expression of fibrinogen fragment D and complement component C3c, and decreased expression of cystatin SA, in the saliva of OLP patients. Statistical differences in the expression of salivary complement C3c were observed between OLP patients and healthy control subjects. Immunoblotting analyses confirmed the results of our ELISA study. Conclusion: Complement C3c, fibrinogen fragment D and cystatin SA may serve as salivary biomarkers for screening and/or diagnosis of OLP. © 2018 The Author(s).
Keyword
Industrial Classification
Knowledge Taxonomy Level 1
Knowledge Taxonomy Level 2
Knowledge Taxonomy Level 3
Funding Sponsor
Mahidol University; Thailand Research Fund
License
CC BY
Rights
Author
Publication Source
Scopus